Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates

Eur J Biochem. 2004 Feb;271(3):607-13. doi: 10.1111/j.1432-1033.2003.03963.x.

Abstract

The reactive site loop of serpins undoubtedly defines in part their ability to inhibit a particular enzyme. Exchanges in the reactive loop of serpins might reassign the targets and modify the serpin-protease interaction kinetics. Based on this concept, we have developed a procedure to change the specificity of known serpins. First, reactive loops are very good substrates for the target enzymes. Therefore, we have used the phage-display technology to select from a pentapeptide phage library the best substrates for the human prostate kallikrein hK2 [Cloutier, S.M., Chagas, J.R., Mach, J.P., Gygi, C.M., Leisinger, H.J. & Deperthes, D. (2002) Eur. J. Biochem. 269, 2747-2754]. Selected substrates were then transplanted into the reactive site loop of alpha1-antichymotrypsin to generate new variants of this serpin, able to inhibit the serine protease. Thus, we have developed some highly specific alpha1-antichymotrypsin variants toward human kallikrein 2 which also show high reactivity. These inhibitors might be useful to help elucidate the importance of hK2 in prostate cancer progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteriophages / genetics*
  • Base Sequence
  • Blotting, Western
  • DNA Primers
  • Humans
  • Hydrolysis
  • Kinetics
  • Mutagenesis, Site-Directed
  • Recombinant Proteins / pharmacology
  • Serine Proteinase Inhibitors / pharmacology*
  • Tissue Kallikreins / antagonists & inhibitors*

Substances

  • DNA Primers
  • Recombinant Proteins
  • Serine Proteinase Inhibitors
  • Tissue Kallikreins